Testing effectiveness (Phase 2)Ended earlyNCT00323011
What this trial is testing
FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer
Who this might be right for
Colorectal Cancer
University of Southern California 5